MY105807A - Medicaments - Google Patents

Medicaments

Info

Publication number
MY105807A
MY105807A MYPI89001112A MYPI19891112A MY105807A MY 105807 A MY105807 A MY 105807A MY PI89001112 A MYPI89001112 A MY PI89001112A MY PI19891112 A MYPI19891112 A MY PI19891112A MY 105807 A MY105807 A MY 105807A
Authority
MY
Malaysia
Prior art keywords
group
novel
naphthoquinones
prophylaxis
positions
Prior art date
Application number
MYPI89001112A
Inventor
Susan Latter Victoria
Edward Gutteridge Winston
Thomas Hudson Alan
Original Assignee
The Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888819477A external-priority patent/GB8819477D0/en
Priority claimed from GB888819478A external-priority patent/GB8819478D0/en
Priority claimed from GB888819480A external-priority patent/GB8819480D0/en
Application filed by The Wellcome Foundation Ltd filed Critical The Wellcome Foundation Ltd
Publication of MY105807A publication Critical patent/MY105807A/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO THE USE OF KNOWN AND NOVEL NAPHTHOQUINONES IN THE TREATMENT AND PROPHYLAXIS OF PNEUMOCYSTIS CARINII INFECTIONS, AND FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT AND PROPHYLAXIS OF P.CARINII INFECTIONS, NOVEL FORMULATIONS CONTAINING SAID COMPOUNDS, AND NOVEL NAPHTHOQUINONES OF FORMULA (V1): WHEREIN R11 AND R12 EACH REPRESENT=O AND THE DOTTED LINE REPRESENTS A DOUBLE BOND BETWEEN THE 2 AND 3 POSITIONS OF THE QUINONE RING, IN WHICH CASE R13 REPRESENTS A GROUP -OCOR5; A GROUP OR6 OR SR6; OR A GROUP NR7R8; OR THE DOTTED LINE REPRESENTS DOUBLE BONDS AT THE 1,2 AND 3,4 POSITIONS OF THE QUINOL RING AND R11, R12 AND R13 EACH REPRESENTS A GROUP -OCOR14, WHEREIN R14 REPRESENTS AN OPTIONALLY SUBTITUTED C1-10 ALKYL GROUP.
MYPI89001112A 1988-08-16 1989-08-15 Medicaments MY105807A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888819477A GB8819477D0 (en) 1988-08-16 1988-08-16 Medicaments
GB888819478A GB8819478D0 (en) 1988-08-16 1988-08-16 Medicaments
GB888819480A GB8819480D0 (en) 1988-08-16 1988-08-16 Medicaments

Publications (1)

Publication Number Publication Date
MY105807A true MY105807A (en) 1995-01-30

Family

ID=79553906

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89001112A MY105807A (en) 1988-08-16 1989-08-15 Medicaments

Country Status (1)

Country Link
MY (1) MY105807A (en)

Similar Documents

Publication Publication Date Title
DK198791A (en) THERAPEUTIC COMBINATIONS OF 3'-AZIDO-3'-DESOXYTHYMIDINE AND OTHER THERAPEUTIC AGENTS
NZ251320A (en) Bis-aromatic alpha,beta-unsaturated ketones, preparation and use in pharmaceutical compositions
ES2032503T3 (en) MEDICATION FOR THE MOUTH CAVITY AREA. (RESERVATION OF ART. 167.2 CPE).
SG23618G (en) Naphthoquinones for the treatment and prophylaxis of pneumocystis carinii infections
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
NZ216172A (en) Nucleosides and pharmaceutical compositions
DE69001880D1 (en) ORAL PREPARATIONS.
GB9224598D0 (en) Novel compositions
CA2124677A1 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
FR2662354B1 (en) USE OF BACLOFENE FOR OBTAINING MEDICINAL PRODUCTS FOR THE TREATMENT OF ANGINA OF CHEST.
PH23778A (en) Labdan compounds,pharmaceutical compositions and use
DE69005165D1 (en) Medicament containing a pharmaceutically acceptable carrier and the compound of the structure (7-alpha, 17-alpha) -17-hydroxy-7-methyl-19-nor-17-pregn-5 (10) -ene-20-yne-3 -one contains.
IL85945A0 (en) Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation
MY105807A (en) Medicaments
GR78622B (en)
JO1493B1 (en) Pharmaceutical compositions for the treatment of high blood pressure
MY102905A (en) Therapeutic nucleosides
RO96600A2 (en) COMPOSED TAMPONATED MEDICAMENT FOR CALCIUM TREATMENT
ITRM910962A1 (en) VITAMIN BIOACTIVATING COMPOUND FOR SKIN.
GB8711424D0 (en) Prophylaxis & treatment of retroviral infections
TH6607B (en) Naphthocinone to be replaced for treating and / or preventing infection. Pneumocystiscarinii
JO1711B1 (en) Therapeutic agents
GR850484B (en)
RO91196B1 (en) Ophthalmic solution
GB1379164A (en) Process for the manufacture of a derivative of alpha-pinene and dedicaments based on this derivative